Cargando…

Is there a limited value of cytoreductive surgery in elderly patients with malignant gliomas?

BACKGROUND: Glioblastoma (GB) is well known for being the most aggressive primary cerebral malignancy. The peak incidence is at 60–70 years of age, with over half of patients aged over 65 years at diagnosis. METHODS: Patients with a confirmed histological diagnosis of GB between January 2009 and Jun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elserius, Anne S. L., Hodson, James, Zisakis, Athanasios, Ughratdar, Ismail
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Scientific Scholar 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345099/ https://www.ncbi.nlm.nih.gov/pubmed/35928314 http://dx.doi.org/10.25259/SNI_438_2022

Ejemplares similares

Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis in the Elderly
por: Spiliotis, J. D., et al.
Publicado: (2014)

COVD-26. TELEPHONE CONSULTATIONS IN NEURO-ONCOLOGY DURING THE COVID-19 PANDEMIC: LEVELS OF PATIENT SATISFACTION AND COMPARISON WITH TRADITIONAL FACE-TO-FACE CONSULTATIONS
por: Toman, Emma, et al.
Publicado: (2020)

Telephone versus face-to-face neuro-oncology consultations: comparing patient satisfaction, convenience, family support and clinician attitude during the COVID-19 pandemic
por: Toman, Emma, et al.
Publicado: (2021)

Reconfiguration from emergency to urgent elective neurosurgery for glioblastoma patients improves length of stay, surgical adjunct use, and extent of resective surgery
por: Sun, Rosa, et al.
Publicado: (2022)

Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly
por: Huang, Yeqian, et al.
Publicado: (2015)

Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?
por: Leigh, Natasha, et al.
Publicado: (2020)

Early sepsis identification following cytoreductive surgery for peritoneal malignancy
por: Wilson, Darius Cameron, et al.
Publicado: (2020)

Laparoscopic Cytoreductive Surgery and HIPEC in Patients with Limited Pseudomyxoma Peritonei of Appendiceal Origin
por: Esquivel, Jesus, et al.
Publicado: (2012)

Do patients undergoing cytoreductive surgery and HIPEC for peritoneal malignancy need parenteral nutrition?
por: Swain, David R., et al.
Publicado: (2018)

Cytoreductive surgery is feasible in patients with limited regional platinum-resistant recurrent ovarian cancer
por: Zou, Ruoyao, et al.
Publicado: (2023)

Cell-Type-Dependent Thyroid Hormone Effects on Glioma Tumor Cell Lines
por: Alexandros, Liappas, et al.
Publicado: (2011)

The value of PET/CT for cytoreductive surgery selection in recurrent ovarian carcinoma
por: Nunes, Rafael Leite, et al.
Publicado: (2023)

Erratum to “Cell-Type-Dependent Thyroid Hormone Effects on Glioma Tumor Cell Lines”
por: Liappas, Alexandros, et al.
Publicado: (2012)

Cytoreductive surgery in ovarian cancer
por: Pomel, Christophe, et al.
Publicado: (2007)

Multifactorial Evaluation following Cytoreductive Surgery for Malignant Pleural Mesothelioma in Patients with High Symptom-Burden
por: Tajè, Riccardo, et al.
Publicado: (2022)

Surgical Management of Malignant Glioma in the Elderly
por: Klingenschmid, Julia, et al.
Publicado: (2022)

Fifth annual workshop of cytoreductive surgery for advanced ovarian cancer and peritoneal surface malignancies
por: Tewari, Krishnansu S.
Publicado: (2016)

Cytoreductive surgery and HIPEC for malignant ascites from colorectal cancer - a randomized study
por: Ba, Mingchen, et al.
Publicado: (2020)

Cytoreductive Surgery of Colorectal Peritoneal Metastases: Outcomes after Complete Cytoreductive Surgery and Systemic Chemotherapy Only
por: Désolneux, Grégoire, et al.
Publicado: (2015)

Limitations of laparoscopy to assess the peritoneal cancer index and eligibility for cytoreductive surgery with HIPEC in peritoneal metastasis
por: Yurttas, Can, et al.
Publicado: (2022)

Fall-Related Emergency Department Admission: Fall Environment and Settings and Related Injury Patterns in 6357 Patients with Special Emphasis on the Elderly
por: Pfortmueller, Carmen A., et al.
Publicado: (2014)

Severe Dyspnea due to Pulmonary Metastasis of Renal Cell Carcinoma: Is Cytoreductive Surgery of Value?
por: Moslemi, Mohammad Kazem, et al.
Publicado: (2010)

Predicting value of HE4 and CA125 markers for optimal cytoreductive surgery in ovarian cancer patients
por: Saffarieh, Elham, et al.
Publicado: (2022)

Prognostic value of preoperative serological biomarkers in patients undergoing cytoreductive surgery for ovarian cancer peritoneal metastases
por: Khaled, Charif, et al.
Publicado: (2023)

The importance of primary tumor origin in gastrointestinal malignancies undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Leigh, Natasha, et al.
Publicado: (2020)

A Canadian single-centre experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for abdominal malignancies
por: Nassabein, Rami, et al.
Publicado: (2022)

Randomized trial of intravenous versus bidirectional chemotherapy after cytoreductive surgery for malignant peritoneal mesothelioma
por: Sugarbaker, Paul H.
Publicado: (2023)

Gastrointestinal Complications in 147 Consecutive Patients with Peritoneal Surface Malignancy Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy
por: Casado-Adam, Angela, et al.
Publicado: (2011)

The Effect of Cytoreductive Partial Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma
por: Chen, Jiabi, et al.
Publicado: (2020)

Cytoreductive surgery in the era of targeted molecular therapy
por: Thomas, Arun Z., et al.
Publicado: (2015)

Cytoreductive surgery for men with metastatic prostate cancer
por: Katelaris, Nikolas, et al.
Publicado: (2016)

The role of cytoreductive surgery in multifocal/multicentric glioblastomas
por: Dimov, Diyan, et al.
Publicado: (2023)

Experience of applying cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian teratoma with malignant transformation and peritoneal dissemination
por: Yu, Hsin-Hsien, et al.
Publicado: (2019)

Biological mesh is a safe and effective method of abdominal wall reconstruction in cytoreductive surgery for peritoneal malignancy
por: Tzivanakis, A., et al.
Publicado: (2018)

Hyperthermic Intrathoracic Chemotherapy (HITOC) after Cytoreductive Surgery for Pleural Malignancies—A Retrospective, Multicentre Study
por: Ried, Michael, et al.
Publicado: (2021)

Impact of sociodemographic factors on outcomes in patients with peritoneal malignancies following cytoreduction and chemoperfusion
por: Cantos, Adriana, et al.
Publicado: (2022)

Morbidity and mortality in women with advanced ovarian cancer who underwent primary cytoreductive surgery compared to cytoreductive surgery for recurrent disease: a meta-analysis
por: Bartels, Helena C., et al.
Publicado: (2019)

Is Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy a Safe and Effective Procedure for Treating Patients With a Peritoneal Surface Malignancy?
por: Park, Dong-Guk
Publicado: (2017)

Treatment of Malignant Gliomas in Elderly Patients: A Concise Overview of the Literature
por: Farina, Patrizia, et al.
Publicado: (2014)

New developments in surgery of malignant gliomas
por: Vranic, Andrej
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_bf592fhm2qd1gmcd9udp9gs9dc